Eric Scott Sills David J Walsh Lyuda V Shkrobot Gianpiero D Palermo Anthony Ph Walsh
Ulster Med J
2009 Jan;78(1):57-8.
NO-CC CODE
https://pubmed.ncbi.nlm.nih.gov/19252735/
Immunoglobulin G / therapeutic use Immunoglobulins, Intravenous / therapeutic use Immunosuppressive Agents / therapeutic use Receptors, Tumor Necrosis Factor / therapeutic use Tumor Necrosis Factor-alpha / antagonists & inhibitors
Immunoglobulin G / therapeutic use Immunoglobulins, Intravenous / therapeutic use Immunosuppressive Agents / therapeutic use Receptors, Tumor Necrosis Factor / therapeutic use Tumor Necrosis Factor-alpha / antagonists & inhibitors Case Reports Letter Adult Cesarean Section Etanercept Female Humans Infant, Newborn Male Pregnancy Recurrence Immunoglobulin G Immunoglobulins, Intravenous Immunosuppressive Agents Receptors, Tumor Necrosis Factor Tumor Necrosis Factor-alpha Etanercept
PMC2629025
19252735
Clinical experience with intravenous immunoglobulin and tnf-a inhibitor therapies for recurrent pregnancy loss
2009